- All
- Product Name
- Product Keyword
- Product Model
- Product Summary
- Product Description
- Multi Field Search
Parameters :hsCRP,HbA1c,mALB,D-Dimer,ASO,RF,C3,C4 etc.can be extended to more than 30 parameters.
GPP-100 is a Point of Care Nephelometry Specific Protein Analyzer for measuring multiple blood tests through a single analyzer. Approved and registered by many MOH worldwide.
This is a fully automatic cartridge-based analyzer for the quantitative determination of specific proteins in the blood, serum, urine samples, including HbA1c, HS-CRP, CRP, ASO, CYS-C, RF, mALB, D-Dimer, IgM, IgG, IgA, C3, C4, etc.
Point of Care Testing (POCT) is any analytical test for human performed by a healthcare professional at the point of patient care, outside of a conventional laboratory setting. Testing this way gives fast access to test results so that clinical decisions can be made immediately.
The NHS Long Term Plan highlights the importance of patients receiving care closer to home, shifting from a traditional model of hospital-based services towards a more adaptive community-based approach. As part of the Community pharmacy contractual framework agreement 2019-2024, NHS England and Improvement committed to explore point of care testing (POCT) by community pharmacists.
Parameters :hsCRP,HbA1c,mALB,D-Dimer,ASO,RF,C3,C4 etc.can be extended to more than 30 parameters.
GPP-100 is a Point of Care Nephelometry Specific Protein Analyzer for measuring multiple blood tests through a single analyzer. Approved and registered by many MOH worldwide.
This is a fully automatic cartridge-based analyzer for the quantitative determination of specific proteins in the blood, serum, urine samples, including HbA1c, HS-CRP, CRP, ASO, CYS-C, RF, mALB, D-Dimer, IgM, IgG, IgA, C3, C4, etc.
Point of Care Testing (POCT) is any analytical test for human performed by a healthcare professional at the point of patient care, outside of a conventional laboratory setting. Testing this way gives fast access to test results so that clinical decisions can be made immediately.
The NHS Long Term Plan highlights the importance of patients receiving care closer to home, shifting from a traditional model of hospital-based services towards a more adaptive community-based approach. As part of the Community pharmacy contractual framework agreement 2019-2024, NHS England and Improvement committed to explore point of care testing (POCT) by community pharmacists.
We offer
